News and Media
Recently Funded Research Grants at IRCE:
THE ISN-NCD study
Prof. Abimiku Alash’le, The Executive Director of the International Research Center of Excellence (IRCE), recently received a grant from ISN Medicals, a Nigerian-based medical diagnostics company to carry out a research study on the prevalence and progression of non-communicable diseases (NCDs) and their risk factors among people living with HIV in Nigeria (ISN-NCD study). This will be a prospective cohort study (n=400) that will aim to recruit and follow 200 newly diagnosed HIV positive clients and 200 HIV negatives at 5 selected secondary and tertiary level IHVN-PEPFAR supported health facilities in Abuja, Nigeria for a period of 2 years. The specific objectives of the study include:
The main outcome measures would include information on the prevalence and incidence of specific NCDs in a cohort of people living with HIV and a clear characterization of risk factors for the development of future NCDs in this cohort. This study will be jointly supervised by Drs. Elima Jedy-Agba, Evaezi Okpokoro and Gbenga Kayode.
The BRIDGE study
Dr. Elima Enaji Jedy-Agba has recently received the 2020 International Innovation Grant of $20,000 from the Conquer Cancer Foundation of the American Society for Clinical Oncology. This funding will support a pilot study aimed at assessing the feasibility and acceptability of a clinic based mobile health application to improve breast cancer early detection and shorten delays to diagnosis in North-central Nigeria (The BRIDGE study).
This project will last 12 months and has the following specific objectives
The proposed study will adopt a mixed-methods approach using qualitative and quantitative methods to gain more understanding of the acceptability and feasibility of using the BRIDGE mobile application in Nigeria. It will be implemented at 6 primary health care centers in the Gwagwalada area council of Abuja, Nigeria. (3 intervention sites and 3 control sites).
The BRIDGE mobile application will be developed in collaboration with SEAM health group, Nigeria and the Department of Global Health, Mount Sinai Hospital, New York, USA.